3rd Edition of
International Ophthalmology Conference
March 10-12, 2025 | Rome, Italy
Cornea and External Diseases
The cornea, which covers the iris, pupil, and anterior chamber, is the transparent front section of the eye. The cornea, along with the anterior chamber and lens, refracts light, accounting for around two-thirds of the total optical power of the eye. Unmyelinated nerve endings in the cornea are sensitive to touch, temperature, and chemicals, and a touch induces an automatic response to close the eyelid. The healthy cornea does not have or require blood vessels because transparency is so important. Corneal and external diseases are ailments that affect the outside layer of the eye. Dry eye, corneal infections, blepharitis, allergies, conjunctivitis, and corneal dystrophies, all of which can produce clouding of the cornea, are some of the most frequent ocular surface diseases.
- Corneal Allotransplantation
- Corneal Dystrophies
- Blepharitis
- Allergic Disease
- Trachoma
- Corneal Trauma
John David Bullock
Wright State University, United States
Edward Charles Kondrot
Healing the Eye Wellness Center, United States
Minckler Don S
UCI Gavin Herbert Eye Institute, United States
Dhruva Drew Gupta
Harvard Medical School, United States
Nour Abou Shousha
Harvard Medical School, United States
George HH Beiko
McMaster Univeresity, Canada
Mustafa Al Ghazi
University Hospital of Wales, United KingdomSubmit your abstract Today
Title : Optic nerve orthograde axonal transport in abusive head trauma suspects
Minckler Don S, UCI Gavin Herbert Eye Institute, United States
Title : Eyes and guts connection: Microbiomes and their role in ocular health
Edward Charles Kondrot, Healing the Eye Wellness Center, United States
Title : Why was Leonhard Euler blind?
John David Bullock, Wright State University, United States
Title : Ultra-widefield protocol enhances automated classification of diabetic retinopathy severity with OCT angiography
Kasra Rezaei, University of Washington, United States
Title : A factorial randomized controlled trial of tissue plasminogen activator and/or perfluoropropane for the treatment of submacular hemorrhage secondary to neovascular age-related macular degeneration (TAPAS)
Tim Jackson, King’s College London, United Kingdom
Title : Developing resilience-based treatments for glaucoma
Simon John, Columbia University, United States